Economic burden of mucormycosis in the United States: can a vaccine be cost-effective?

Title
Economic burden of mucormycosis in the United States: can a vaccine be cost-effective?
Authors
Keywords
-
Journal
MEDICAL MYCOLOGY
Volume 47, Issue 6, Pages 592-600
Publisher
Oxford University Press (OUP)
Online
2008-09-17
DOI
10.1080/13693780802326001

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation